
    
      DEX as an anesthetic adjuvant improved hemodynamic stability and decreased anesthetic
      requirements in patients undergoing TNTS resection of pituitary tumor. In addition, DEX
      provided better surgical field exposure conditions and early recovery from anesthesia
    
  